FATE THERAPEUTICS INC
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $1.1M | $63.9M | $40.6M |
| Jun 2017 | $6.7M | $55.2M | $31.1M |
| Sep 2017 | $14.8M | $45.7M | $43.2M |
| Dec 2017 | $14.8M | $77.2M | $89.0M |
| Mar 2018 | $14.1M | $65.0M | $32.9M |
| Jun 2018 | $12.8M | $51.8M | $36.2M |
| Sep 2018 | $11.6M | $173.9M | $183.2M |
| Dec 2018 | $12.4M | $160.5M | $190.5M |
| Mar 2019 | $11.0M | $145.8M | $183.0M |
| Jun 2019 | $9.5M | $127.5M | $71.4M |
| Sep 2019 | — | $268.0M | $249.6M |
| Dec 2019 | — | $244.8M | $99.8M |
| Mar 2020 | — | $219.2M | $83.4M |
| Jun 2020 | — | $474.1M | $433.1M |
| Sep 2020 | — | $424.4M | $349.1M |
| Dec 2020 | — | $384.4M | $167.3M |
| Mar 2021 | — | $790.1M | $106.4M |
| Jun 2021 | — | $752.1M | $76.7M |
| Sep 2021 | — | $730.3M | $129.2M |
| Dec 2021 | — | $678.8M | $133.6M |
| Mar 2022 | — | $633.4M | $64.7M |
| Jun 2022 | — | $580.5M | $55.3M |
| Sep 2022 | — | $518.0M | $82.1M |
| Dec 2022 | — | $483.9M | $61.3M |
| Mar 2023 | — | $477.5M | $42.0M |
| Jun 2023 | — | $437.8M | $46.8M |
| Sep 2023 | — | $402.8M | $33.3M |
| Dec 2023 | — | $368.4M | $41.9M |
| Mar 2024 | — | $426.1M | $121.3M |
| Jun 2024 | — | $397.0M | $36.9M |
| Sep 2024 | — | $362.3M | $37.9M |
| Dec 2024 | — | $318.7M | $36.1M |
| Mar 2025 | — | $288.4M | $44.9M |
| Jun 2025 | — | $261.4M | $41.2M |
| Sep 2025 | — | $234.1M | $40.6M |
| Dec 2025 | — | $207.2M | $46.6M |
| Mar 2026 | — | $179.7M | $39.6M |
| Jun 2026 | — | $153.4M | $32.4M |